+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology



Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology



Clinical and Diagnostic Laboratory Immunology 1(4): 373-378



Fifty-one patients with erythema migrans were followed up prospectively with serial clinical evaluations, serologic determinations for antiborrelial antibodies, and lymphocyte stimulation responses to Borrelia burgdorferi antigens to determine (i) the factors associated with sustained cellular immune responses and (ii) whether lymphocyte stimulation is a good indicator of prior exposure to B. burgdorferi in patients treated early after erythema migrans. Positive lymphocyte stimulation responses ( gt 2 standard deviations above normal control values) were found in 15 (29%) of 51 patients 3 months after treatment for erythema migrans and in 8 (18%) of 44 patients 1 year posttreatment. Heightened lymphocyte responses were not associated with the number or duration of erythema migrans lesions prior to treatment, the mean size of the largest erythema migrans lesion, or the number of symptoms at the time of presentation. The development of a Jarisch-Herxheimer reaction, choice of antibiotic, and clinical outcome also were not associated with a positive lymphoproliferation assay result. Changes in the lymphocyte stimulation indices between the two time points assessed (3 months and I year posttreatment) also did not correlate with the above variables. When serologic results and lymphoproliferative responses were evaluated as categorical or continuous variables, there were no correlations between values. One year after treatment for early Lyme disease, lymphocyte reactivity is not a good indicator of prior infection with B. burgdoferi.

(PDF emailed within 1 workday: $29.90)

Accession: 002973855

Download citation: RISBibTeXText

PMID: 8556471


Related references

Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. Journal of Clinical Investigation 90(3): 1077-1084, 1992

Cellular immune responses to Borrelia burgdorferi in Lyme disease. Clinical Immunology Newsletter 11(8): 112, 118-124, 1991

Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infection and Immunity 69(12): 7437-7444, 2001

Borrelia burgdorferi specific cellular and humoral immune responses within the central nervous system during chronic lyme meningoradiculitis and radiculomyelitis. Zentralblatt fuer Bakteriologie Supplement 18: 82-92, 1990

Borrelia burgdorferi clinical isolates induce human innate immune responses that are not dependent on genotype. Immunobiology 220(10): 1141-1150, 2016

Immune response to 3 different strains of Borrelia burgdorferi in patients with Lyme arthritis Correlation between reactivity to outer-surface proteins A and B and clinical pattern. Arthritis & Rheumatism 35(9 SUPPL ): S184, 1992

Immune responses to P. falciparum-MSP1 antigen: Lack of correlation between antibody responses and the capacity of peripheral cellular immune effectors to respond to this antigen in vitro. Immunology Letters 67(3): 217-221, April 15, 1999

Cellular immune response to Borrelia burgdorferi antigens. Giornale di Malattie Infettive e Parassitarie 45(5): 420-423, 1993

Lack of correlation between exposure to Lyme disease (Borrelia burgdorferi) and pregnancy loss in mares. Journal of Equine Veterinary Science 14(2): 102-105, 1994

In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto. Journal of Clinical Microbiology 41(4): 1791-1793, 2003

Cellular immune response to Borrelia burgdorferi in patients with Lyme borreliosis. Behring Institute Mitteilungen: 52-58, 1991

Immune responses to Borrelia burgdorferi in patients with reactive arthritis. Arthritis and Rheumatism 32(9): 1057-1064, 1989

Lyme disease: antigens of Borrelia burgdorferi and immune responses to them. Annals of the New York Academy of Sciences 539: 112-114, 1988